Tuesday, 16 April 2024
Abano Healthcare Group Limited Ordinary Shares
-
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
Note: This form must be completed in accordance with the instructions at the
end of the form.
To New Zealand Exchange
and
To Abano Healthcare Group Ltd
Relevant event being disclosed: Movement of 1% or more in the substantial
holding
Date of relevant event: 31 Ja
more»
-
Please see attached Ongoing Disclosure Notices for:
- Eduard Koert van Arkel
- Trevor David Janes
- Rachel Jane Walsh
- Philippa Jane Dunphy
- Murray Raymond Boyte
- Dr Ginni Mansberg
- Danny Chan
- Andrew Richard Purcell Tapper
of Abano Healthcare Group Limited ("ABA").
End CA:00313331 For:ABA Type:SHINTR Time:2018-01-23 09:26:35
more»
-
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
Note: This form must be completed in accordance with the instructions at the
end of the form.
To New Zealand Exchange
and
To Abano Healthcare Group Ltd
Relevant event being disclosed: Movement of 1% or more in the substantial
holding
Date of relevant event: 19 Janu
more»
-
NOTICE PURSUANT TO LISTING RULE 7.12.1
19 January 2018
To: NZX Limited
ORDINARY SHARES
For the purposes of NZX Main Board Listing Rule 7.12.1, Abano Healthcare
Group Limited advises the following in respect of the issue of new ordinary
shares:
Listing Rule 7.12.1
(a) Class of Security and ISIN: Fully paid ordinary shares.
ISIN: NZNPEE0001S8
(b) Number issued: 108,267 ordinary shares
(c) Nominal value/issue prices: $1,044,
more»
-
Abano Healthcare Group Limited (NZX:ABA) advises that the issue price for
shares issued in lieu of the cash 2018 Interim Dividend under its Dividend
Reinvestment Plan (DRP) is $9.65 per share.
The issue price has been determined, in accordance with the DRP, as the
volume weighted average sale price for all Abano shares sold on the NZX over
the five trading days immediately following the record date of 9 January
2018, less a 2.5% discount.
more»
-
The board of directors of Abano Healthcare Group Limited (NZX: ABA) has
approved administrative amendments to Abano''s Dividend Reinvestment Plan. The
updated Dividend Reinvestment Plan offer document and participation notice
are attached.
ENDS
End CA:00312298 For:ABA Type:OFFER Time:2017-12-21 09:24:07
more»
-
ABANO DELIVERS RECORD HALF YEAR RESULT IN LINE WITH GUIDANCE
Results for the six months to 30 November 2017
o Abano confirms record half year result in line with guidance
o Result driven by acquisition growth in the dental business, improving
dental same store sales growth and a solid performance in radiology
o Interim dividend of 16 cents per share declared
Abano Healthcare Group Limited (NZX:ABA) has today reported a lift in both
rev
more»
-
ABANO ANNOUNCES SALE OF ASCOT RADIOLOGY TO CLINICAL PARTNERS
Abano Healthcare Group Limited (NZX:ABA) advises that it has entered into an
agreement to sell its 71% shareholding in Ascot Radiology to its radiologist
shareholders for a total consideration of $17.0 million.
The sale will provide a one-off gain of approximately $2.1 million after
costs which will be reported in Abano''s FY18 full year results. Settlement is
expected to occu
more»
-
Abano Healthcare Group has today released the November 2017 issue of its
regular shareholder newsletter.
Included in this issue:
Management Commentary - Investing in our Business
Half year FY18 Guidance (as previously announced)
Summer intern at Abano
Dental News:
- Dental online bookings a hit
- Proudmouth Auckland on the move
- Doors open at Lumino Rangiora
- Smiles all around for first ever Maven Dental Day
Radiology News: St He
more»
-
Disclosure of movement of 1% or more in substantial holding or change in
nature of relevant interest, or both
Section 277 and 278, Financial Markets Conduct Act 2013
To: NZX Limited
and
To: Abano Healthcare Group Limited
Date of relevant event: 28 November 2017
Date of this disclosure: 29 November 2017
Date last disclosure made: 11 October 2017
Substantial product holder(s) giving disclosure:
Full name(s): Forsyth Barr In
more»
| Code | Last | Change |
|---|
| COMP | 10,321 | 328 |  | 3.08% |
| DJI | 29,635 | 404 | | 1.34% |
| SP500 | 3,583 | 87 | | 2.37% |
| DAX | 12,438 | 82 |  | 0.67% |
| FTSE | 7,488 | 5 | | 0.07% |
| NI225 | 22,420 | 408 | | 1.86% |
| TWI | 67.27 | 0.00 |  | 0.00% |